Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 6/20 | 0.40 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TK2 | O00142 | 3/20 | 0.37 |
| ▸ | NT5M | Q9NPB1 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | TYMP | P19971 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11981102 | 0.88 | TK1 (0.44) | TK1RNASE1HPGDTK2NT5M | |
| SCHEMBL14946306 | 0.88 | TK1 (0.44) | TK1RNASE1HPGDTK2NT5M | |
| SCHEMBL25967797 | 0.87 | TK1 (0.44) | TK1HPGDTK2 | |
| SCHEMBL17356765 | 0.86 | TK1 (0.41) | TK1RNASE1HPGDTK2NT5M | |
| SCHEMBL20394084 | 0.85 | TK1 (0.36) | TK1RNASE1TK2NT5MBCHE | |
| SCHEMBL11981123 | 0.85 | TK1 (0.42) | TK1RNASE1HPGDTK2NT5M | |
| SCHEMBL23152977 | 0.84 | TK1 (0.41) | TK1RNASE1HPGDTK2NT5M | |
| SCHEMBL26135487 | 0.82 | TK1 (0.42) | TK1RNASE1HPGDTK2NT5M | |
| SCHEMBL26135489 | 0.82 | TK1 (0.42) | TK1RNASE1HPGDTK2NT5M | |
| SCHEMBL16648575 | 0.81 | TK1 (0.38) | TK1RNASE1HPGDTK2NT5M |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257413-A1 | ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE THEREOF | RIKEN GENESIS CO., LTD. (JP) | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257413-A1 | ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE THEREOF | NSUN2, NSUN3, POLRMT | TK1 1395/4885RNASE1 56/4885HPGD 4078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.